Speaking Engagements
 
Email Page
Chad Landmon Speaks on "How to Align the FDA Approval Process with Paragraph IV Strategy"

On June 2, 2011, Chad Landmon, Chair of the FDA Practice Group at Axinn, Veltrop & Harkrider LLP, delivered an FDAnews Webinar entitled, “How to Align the FDA Approval Process with Paragraph IV Strategy: Tips, Best Practices and Case Studies to Optimize FDA Results.” The presentation discussed strategies toproactively approach Paragraph IV litigation in order to better serve a company's overall business goals. Details on the webinar can be found here:  CTDOCS-42686-v1-FDAnews_PIV_Disputes_Webinar.PPT